Screening of Chemical Libraries for New Antifungal Drugs against <named-content content-type="genus-species">Aspergillus fumigatus</named-content> Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine

ABSTRACT Aspergillus fumigatus is an important fungal pathogen and the main etiological agent of aspergillosis, a disease characterized by a noninvasive process that can evolve to a more severe clinical manifestation, called invasive pulmonary aspergillosis (IPA), in immunocompromised patients. The...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Thaila Fernanda dos Reis, Maria Augusta Crivelente Horta, Ana Cristina Colabardini, Caroline Mota Fernandes, Lilian Pereira Silva, Rafael Wesley Bastos, Maria Vitória de Lazari Fonseca, Fang Wang, Celso Martins, Márcio L. Rodrigues, Cristina Silva Pereira, Maurizio Del Poeta, Koon Ho Wong, Gustavo H. Goldman
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://doaj.org/article/df0e79e5ab2e41ef86dd3dc64c5b821a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:df0e79e5ab2e41ef86dd3dc64c5b821a
record_format dspace
spelling oai:doaj.org-article:df0e79e5ab2e41ef86dd3dc64c5b821a2021-11-10T18:37:50ZScreening of Chemical Libraries for New Antifungal Drugs against <named-content content-type="genus-species">Aspergillus fumigatus</named-content> Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine10.1128/mBio.01458-212150-7511https://doaj.org/article/df0e79e5ab2e41ef86dd3dc64c5b821a2021-08-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01458-21https://doaj.org/toc/2150-7511ABSTRACT Aspergillus fumigatus is an important fungal pathogen and the main etiological agent of aspergillosis, a disease characterized by a noninvasive process that can evolve to a more severe clinical manifestation, called invasive pulmonary aspergillosis (IPA), in immunocompromised patients. The antifungal arsenal to threat aspergillosis is very restricted. Azoles are the main therapeutic approach to control IPA, but the emergence of azole-resistant A. fumigatus isolates has significantly increased over recent decades. Therefore, new strategies are necessary to combat aspergillosis, and drug repurposing has emerged as an efficient and alternative approach for identifying new antifungal drugs. Here, we used a screening approach to analyze A. fumigatus in vitro susceptibility to 1,127 compounds. A. fumigatus was susceptible to 10 compounds, including miltefosine, a drug that displayed fungicidal activity against A. fumigatus. By screening an A. fumigatus transcription factor null library, we identified a single mutant, which has the smiA (sensitive to miltefosine) gene deleted, conferring a phenotype of susceptibility to miltefosine. The transcriptional profiling (RNA-seq) of the wild-type and ΔsmiA strains and chromatin immunoprecipitation coupled to next-generation sequencing (ChIP-Seq) of an SmiA-tagged strain exposed to miltefosine revealed genes of the sphingolipid pathway that are directly or indirectly regulated by SmiA. Sphingolipid analysis demonstrated that the mutant has overall decreased levels of sphingolipids when growing in the presence of miltefosine. The identification of SmiA represents the first genetic element described and characterized that plays a direct role in miltefosine response in fungi. IMPORTANCE The filamentous fungus Aspergillus fumigatus causes a group of diseases named aspergillosis, and their development occurs after the inhalation of conidia dispersed in the environment. Very few classes of antifungal drugs are available for aspergillosis treatment, e.g., azoles, but the emergence of global resistance to azoles in A. fumigatus clinical isolates has increased over recent decades. Repositioning or repurposing drugs already available on the market is an interesting and faster opportunity for the identification of novel antifungal agents. By using a repurposing strategy, we identified 10 different compounds that impact A. fumigatus survival. One of these compounds, miltefosine, demonstrated fungicidal activity against A. fumigatus. The mechanism of action of miltefosine is unknown, and, aiming to get more insights about it, we identified a transcription factor, SmiA (sensitive to miltefosine), important for miltefosine resistance. Our results suggest that miltefosine displays antifungal activity against A. fumigatus, interfering in sphingolipid biosynthesis.Thaila Fernanda dos ReisMaria Augusta Crivelente HortaAna Cristina ColabardiniCaroline Mota FernandesLilian Pereira SilvaRafael Wesley BastosMaria Vitória de Lazari FonsecaFang WangCelso MartinsMárcio L. RodriguesCristina Silva PereiraMaurizio Del PoetaKoon Ho WongGustavo H. GoldmanAmerican Society for MicrobiologyarticleAspergillus fumigatusdrug repurposingmiltefosinesphingolipidstranscription factorMicrobiologyQR1-502ENmBio, Vol 12, Iss 4 (2021)
institution DOAJ
collection DOAJ
language EN
topic Aspergillus fumigatus
drug repurposing
miltefosine
sphingolipids
transcription factor
Microbiology
QR1-502
spellingShingle Aspergillus fumigatus
drug repurposing
miltefosine
sphingolipids
transcription factor
Microbiology
QR1-502
Thaila Fernanda dos Reis
Maria Augusta Crivelente Horta
Ana Cristina Colabardini
Caroline Mota Fernandes
Lilian Pereira Silva
Rafael Wesley Bastos
Maria Vitória de Lazari Fonseca
Fang Wang
Celso Martins
Márcio L. Rodrigues
Cristina Silva Pereira
Maurizio Del Poeta
Koon Ho Wong
Gustavo H. Goldman
Screening of Chemical Libraries for New Antifungal Drugs against <named-content content-type="genus-species">Aspergillus fumigatus</named-content> Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine
description ABSTRACT Aspergillus fumigatus is an important fungal pathogen and the main etiological agent of aspergillosis, a disease characterized by a noninvasive process that can evolve to a more severe clinical manifestation, called invasive pulmonary aspergillosis (IPA), in immunocompromised patients. The antifungal arsenal to threat aspergillosis is very restricted. Azoles are the main therapeutic approach to control IPA, but the emergence of azole-resistant A. fumigatus isolates has significantly increased over recent decades. Therefore, new strategies are necessary to combat aspergillosis, and drug repurposing has emerged as an efficient and alternative approach for identifying new antifungal drugs. Here, we used a screening approach to analyze A. fumigatus in vitro susceptibility to 1,127 compounds. A. fumigatus was susceptible to 10 compounds, including miltefosine, a drug that displayed fungicidal activity against A. fumigatus. By screening an A. fumigatus transcription factor null library, we identified a single mutant, which has the smiA (sensitive to miltefosine) gene deleted, conferring a phenotype of susceptibility to miltefosine. The transcriptional profiling (RNA-seq) of the wild-type and ΔsmiA strains and chromatin immunoprecipitation coupled to next-generation sequencing (ChIP-Seq) of an SmiA-tagged strain exposed to miltefosine revealed genes of the sphingolipid pathway that are directly or indirectly regulated by SmiA. Sphingolipid analysis demonstrated that the mutant has overall decreased levels of sphingolipids when growing in the presence of miltefosine. The identification of SmiA represents the first genetic element described and characterized that plays a direct role in miltefosine response in fungi. IMPORTANCE The filamentous fungus Aspergillus fumigatus causes a group of diseases named aspergillosis, and their development occurs after the inhalation of conidia dispersed in the environment. Very few classes of antifungal drugs are available for aspergillosis treatment, e.g., azoles, but the emergence of global resistance to azoles in A. fumigatus clinical isolates has increased over recent decades. Repositioning or repurposing drugs already available on the market is an interesting and faster opportunity for the identification of novel antifungal agents. By using a repurposing strategy, we identified 10 different compounds that impact A. fumigatus survival. One of these compounds, miltefosine, demonstrated fungicidal activity against A. fumigatus. The mechanism of action of miltefosine is unknown, and, aiming to get more insights about it, we identified a transcription factor, SmiA (sensitive to miltefosine), important for miltefosine resistance. Our results suggest that miltefosine displays antifungal activity against A. fumigatus, interfering in sphingolipid biosynthesis.
format article
author Thaila Fernanda dos Reis
Maria Augusta Crivelente Horta
Ana Cristina Colabardini
Caroline Mota Fernandes
Lilian Pereira Silva
Rafael Wesley Bastos
Maria Vitória de Lazari Fonseca
Fang Wang
Celso Martins
Márcio L. Rodrigues
Cristina Silva Pereira
Maurizio Del Poeta
Koon Ho Wong
Gustavo H. Goldman
author_facet Thaila Fernanda dos Reis
Maria Augusta Crivelente Horta
Ana Cristina Colabardini
Caroline Mota Fernandes
Lilian Pereira Silva
Rafael Wesley Bastos
Maria Vitória de Lazari Fonseca
Fang Wang
Celso Martins
Márcio L. Rodrigues
Cristina Silva Pereira
Maurizio Del Poeta
Koon Ho Wong
Gustavo H. Goldman
author_sort Thaila Fernanda dos Reis
title Screening of Chemical Libraries for New Antifungal Drugs against <named-content content-type="genus-species">Aspergillus fumigatus</named-content> Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine
title_short Screening of Chemical Libraries for New Antifungal Drugs against <named-content content-type="genus-species">Aspergillus fumigatus</named-content> Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine
title_full Screening of Chemical Libraries for New Antifungal Drugs against <named-content content-type="genus-species">Aspergillus fumigatus</named-content> Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine
title_fullStr Screening of Chemical Libraries for New Antifungal Drugs against <named-content content-type="genus-species">Aspergillus fumigatus</named-content> Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine
title_full_unstemmed Screening of Chemical Libraries for New Antifungal Drugs against <named-content content-type="genus-species">Aspergillus fumigatus</named-content> Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine
title_sort screening of chemical libraries for new antifungal drugs against <named-content content-type="genus-species">aspergillus fumigatus</named-content> reveals sphingolipids are involved in the mechanism of action of miltefosine
publisher American Society for Microbiology
publishDate 2021
url https://doaj.org/article/df0e79e5ab2e41ef86dd3dc64c5b821a
work_keys_str_mv AT thailafernandadosreis screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine
AT mariaaugustacrivelentehorta screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine
AT anacristinacolabardini screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine
AT carolinemotafernandes screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine
AT lilianpereirasilva screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine
AT rafaelwesleybastos screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine
AT mariavitoriadelazarifonseca screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine
AT fangwang screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine
AT celsomartins screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine
AT marciolrodrigues screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine
AT cristinasilvapereira screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine
AT mauriziodelpoeta screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine
AT koonhowong screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine
AT gustavohgoldman screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine
_version_ 1718439929923502080